BREAKING
Atour Lifestyle Reports $0.33 Q4 EPS, Down 86.1% YoY, as Revenue Surges 33.8% to $2.79B 1 minute ago TME Earnings Miss: Q4 EPS of $0.23 Falls Short of Estimates 15 minutes ago XOMA Reports Wednesday Morning as Healthcare Earnings Dominate Sparse Week 39 minutes ago HUYA Stock Plunges: Q4 Revenue Crashes 83.4% YoY to $248.6M, Misses EPS by 106.5% 44 minutes ago Monte Rosa (GLUE) Reports Wider Q4 Loss of $0.55/Share vs $0.34 Estimate, Revenue Misses 1 hour ago Monte Rosa Therapeutics, Inc. (GLUE) Reports Wider Loss Q4 EPS Estimates by 63.4% 1 hour ago Coda Octopus (CODA) Beats Q1 Estimates with $0.08 EPS, Revenue Surges 28.6% YoY to $6.7M 1 hour ago Bicycle Therapeutics (BCYC) Q4 Revenue Soars 1194.5% YoY to $48M, Crushing Estimates by 578% 1 hour ago Getty Images (GETY) Q4 Revenue Surges 14.1% YoY to $282.3M 2 hours ago FINV Stock: 8 Analysts Issue Buy-or-Better Ratings as FinVolution Delivers $0.25 EPS on Flat Revenue 2 hours ago Atour Lifestyle Reports $0.33 Q4 EPS, Down 86.1% YoY, as Revenue Surges 33.8% to $2.79B 1 minute ago TME Earnings Miss: Q4 EPS of $0.23 Falls Short of Estimates 15 minutes ago XOMA Reports Wednesday Morning as Healthcare Earnings Dominate Sparse Week 39 minutes ago HUYA Stock Plunges: Q4 Revenue Crashes 83.4% YoY to $248.6M, Misses EPS by 106.5% 44 minutes ago Monte Rosa (GLUE) Reports Wider Q4 Loss of $0.55/Share vs $0.34 Estimate, Revenue Misses 1 hour ago Monte Rosa Therapeutics, Inc. (GLUE) Reports Wider Loss Q4 EPS Estimates by 63.4% 1 hour ago Coda Octopus (CODA) Beats Q1 Estimates with $0.08 EPS, Revenue Surges 28.6% YoY to $6.7M 1 hour ago Bicycle Therapeutics (BCYC) Q4 Revenue Soars 1194.5% YoY to $48M, Crushing Estimates by 578% 1 hour ago Getty Images (GETY) Q4 Revenue Surges 14.1% YoY to $282.3M 2 hours ago FINV Stock: 8 Analysts Issue Buy-or-Better Ratings as FinVolution Delivers $0.25 EPS on Flat Revenue 2 hours ago
ADVERTISEMENT
Market News

Record $80.4M Revenue Extends Agilysys Growth Streak

Agilysys, Inc. (Nasdaq: AGYS) shares recorded a decline during Tuesday’s session following the release of third-quarter fiscal 2026 results. The company reported its 16th consecutive quarter of record revenue, although bottom-line figures fell short of consensus analyst expectations. Market Capitalization The market capitalization for Agilysys, Inc. is currently approximately $3.02 billion. Latest Quarterly Results For […]

January 26, 2026 1 min read

Agilysys, Inc. (Nasdaq: AGYS) shares recorded a decline during Tuesday’s session following the release of third-quarter fiscal 2026 results. The company reported its 16th consecutive quarter of record revenue, although bottom-line figures fell short of consensus analyst expectations. Market Capitalization The market capitalization for Agilysys, Inc. is currently approximately $3.02 billion. Latest Quarterly Results For […]

Market Capitalization

Latest Quarterly Results

For the third quarter ended December 31, 2025, Agilysys reported record revenue of $80.4 million, an increase of 15.6% compared to $69.6 million in the prior-year period. Net income for the quarter reached $9.9 million, or $0.35 per diluted share, representing an increase from $3.8 million in the third quarter of fiscal 2025.

Revenue by segment includes:

  • Total Recurring Revenue: $52.0 million, accounting for 64.7% of total net revenue.
  • Subscription Revenue: $34.8 million, a 23.1% increase year-over-year.
  • Professional Services: $17.7 million, a 22.0% increase year-over-year.
  • Product Revenue: $10.7 million, compared to $11.4 million in the prior-year period.

Full-Year Results Context

In fiscal year 2025, the company reported total annual revenue of $237.5 million. The current year-to-date performance indicates a trajectory exceeding previous annual records, supported by a 37.0% increase in year-to-date subscription bookings.

ADVERTISEMENT